All Inquiries

Contact Us

Reach out to us if you’d like to request a quote for our services, submit your study, demo our data or just have a general inquiry. For any non-sales inquiries please see the options below the form or skip to them here.

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research.

Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560

Find us on:

Talk with a Metabolomics expert

Client Support

Sample shipments, project updates, portal support, & more.

Careers & Recruiting

Join our dynamic and talented team.

Vendor Inquiries & Invoicing

Accounting services, invoices & payment statuses, etc.

Employee/Income Verification

Request verification for Metabolon current and former associates.

Former Employee Support

Human resources requests, tax documents, etc.

Location/Mailing Information

Corporate locations, phone/fax information & more.

Contact Us

Client Support

For information about shipping your samples, including:

  • Directions for completing your sample manifest
  • Sample preparation and shipment procedures
  • Sample handling kit instructions
  • International shipment information

please visit our Sample Shipment Resources page using the button below.

For other support requests, please contact our client support team using one of the following options:

Client Services Email: clientsuccess@metabolon.com

Client Services Phone: +1 (919) 572-1711

Client Success Address: 617 Davis Drive, Suite 100, Morrisville, NC 27560

If you have a question about a payment or invoice, you may get in touch with our Accounts Receivable team listed below.

Accounts Receivable Email: AR@metabolon.com

Contact Us

Careers & Reruiting

We enable scientific discoveries that make a difference! Our company is a global highly cross-functional team spanning across R&D, Operations, Technology and AI, US and International Sales, Global Marketing and Administrative.

If you have additional questions about careers at Metabolon, please send an email to HR@metabolon.com

Contact Us

Vendors Inquiries & Invoicing

If you are a Metabolon vendor and have questions about invoicing, supplier documentation, etc., you may get in touch with our Accounts Payable listed below.

Accounts Payable Email: AP@metabolon.com

If you are a client of Metabolon and have a question about a payment or invoice, you may get in touch with our Accounts Receivable team listed below.

Accounts Receivable Email: AR@metabolon.com

    Contact Us

    Employment & Income Verification

    To request verification of employment or income, please send an email to Metabolon’s Human Resources team at HR@metabolon.com.

    Contact Us

    Former Employee Support

    If you are a former Metabolon employee and have a support request (tax forms, COBRA/insurance information, other benefits questions, etc.), please send an email to Metabolon’s Human Resources team at HR@metabolon.com.

    Contact Us

    Location & Mailing Information

    Corporate Headquarters

    617 Davis Drive, Suite 100
    Morrisville, NC 27560

    References

    1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

    2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

    3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

    4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

    5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

    6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

    7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

    8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

    9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

    10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

    11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

    12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

    13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

    14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

    15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

    16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

    17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

    18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

    19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

    20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

    21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

    22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

    23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

    24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

    25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

    26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

    27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

    28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.